HIV infection is independently associated with frailty in middle-aged HIV type 1-infected individuals compared with similar but uninfected controls

AIDS

Volumn 30, Issue 2, 2016, Pages 241-250

  Kooij, Katherine W ^a   Wit, Ferdinand W N M ^a,b   Schouten, Judith ^a   Van Der Valk, Marc ^b   Godfried, Mieke H ^b   Stolte, Ineke G ^b,c   Prins, Maria ^b,c   Falutz, Julian ^d   Reiss, Peter ^a,b,e  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b Center for Infection and Immunity Amsterdam CINIMA   (Netherlands)

^c DEPARTMENT OF INFECTIOUS DISEASES   (Netherlands)

^d MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^e STICHTING HIV MONITORING   (Netherlands)

Author keywords

Abdominal obesity; Aging; Frailty; HIV; Lipodystrophy

Indexed keywords

ANTIRETROVIRUS AGENT; D DIMER; PROTEINASE INHIBITOR; STAVUDINE; VIRUS RNA;

ABDOMINAL OBESITY; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ANTIVIRAL THERAPY; ARTICLE; BODY COMPOSITION; BODY MASS; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; FRAIL ELDERLY; HIP CIRCUMFERENCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFLAMMATION; LIPODYSTROPHY; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MIDDLE AGED; PATIENT ASSESSMENT; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SMOKING; TREATMENT DURATION; VIRUS LOAD; WAIST HIP RATIO; COMPLICATION; HEALTH STATUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOLATION AND PURIFICATION; PATHOLOGY; VERY ELDERLY; VIROLOGY;

AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; HEALTH STATUS; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED;

EID: 84952951507     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000000910     Document Type: Article

References (31)

1. Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001; 56:M146-156.
2. Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people. Lancet 2013; 381:752-762.
3. Desquilbet L, Jacobson LP, Fried LP, Phair JP, Jamieson BD, Holloway M, et al. HIV-1 infection is associated with an earlier occurrence of a phenotype related to frailty. J Gerontol A Biol Sci Med Sci 2007; 62:1279-1286.
4. Terzian AS, Holman S, Nathwani N, Robison E, Weber K, Young M, et al. Factors associated with preclinical disability and frailty among HIV-infected and HIV-uninfected women in the era of cART. J Womens Health (Larchmt) 2009; 18:1965-1974.
5. Pathai S, Gilbert C, Weiss HA, Cook C, Wood R, Bekker L-G, et al. Frailty in HIV-infected adults in South Africa. J Acquir Immune Defic Syndr 2013; 62:43-51.
6. Piggott DA, Muzaale AD, Mehta SH, Brown TT, Patel KV, Leng SX, et al. Frailty, HIV infection, and mortality in an aging cohort of injection drug users. PLoS ONE 2013; 8:e54910.
7. Althoff KN, Jacobson LP, Cranston RD, Detels R, Phair JP, Li X, et al. Age, comorbidities, and AIDS predict a frailty phenotype in men who have sex with men. J Gerontol A Biol Sci Med Sci 2014; 69:189-198.
8. Desquilbet L, Margolick JB, Fried LP, Phair JP, Jamieson BD, Holloway M, et al. Relationship between a frailty-related phenotype and progressive deterioration of the immune system in HIV-infected men. J Acquir Immune Defic Syndr 2009; 50:299-306.
9. Ianas V, Berg E, Mohler MJ, Wendel C, Klotz SA. Antiretroviral therapy protects against frailty in HIV-1 infection. J Int Assoc Provid AIDS Care 2013; 12:62-66.
10. Hubbard RE, O'Mahony MS, Savva GM, Calver BL, Woodhouse KW. Inflammation and frailty measures in older people. J Cell Mol Med 2009; 13:3103-3109.
11. Walston J, McBurnie MA, Newman A, Tracy RP, Kop WJ, Hirsch CH, et al. Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study. Arch Intern Med 2002; 162:2333-2341.
12. Leng SX, Xue Q-L, Tian J, Walston JD, Fried LP. Inflammation and frailty in older women. J Am Geriatr Soc 2007; 55:864-871.
13. Margolick J, Martinez-Maza O, Jacobson L, Lopez J, Li X, Phair J, et al. Frailty and circulating markers of inflammation in HIVR and HIV-men in the multicenter AIDS Cohort Study. 20th Conference on Retroviruses and Opportunistic Infections, Atlanta, Georgia, USA; 2013.
14. Erlandson KM, Allshouse A A, Jankowski C M, Lee E J, Rufner K M, Palmer B E, et al. Association of functional impairment with inflammation and immune activation in HIV type 1-infected adults receiving effective antiretroviral therapy. J Infect Dis 2013; 208:249-259.
15. Hubbard RE, Lang IA, Llewellyn DJ, Rockwood K. Frailty, body mass index, and abdominal obesity in older people. J Gerontol A Biol Sci Med Sci 2010; 65:377-381.
16. Strandberg TE, Sirola J, Pitkälä KH, Tilvis RS, Strandberg AY, Stenholm S. Association of midlife obesity and cardiovascular risk with old age frailty: a 26-year follow-up of initially healthy men. Int J Obes (Lond) 2012; 36:1153-1157.
17. Shah K, Hilton TN, Myers L, Pinto JF, Luque AE, Hall WJ. A new frailty syndrome: central obesity and frailty in older adults with the human immunodeficiency virus. J Am Geriatr Soc 2012; 60:545-549.
18. Stanley TL, Grinspoon SK. Body composition and metabolic changes in HIV-infected patients. J Infect Dis 2012; 205 (Suppl 3):S383-390.
19. Schouten J, Wit FW, Stolte IG, Kootstra NA, van der Valk M, Geerlings SE, et al. Cross-sectional comparison of the prevalence of age-associated comorbidities and their risk factors between HIV-infected and uninfected individuals: the AGEhIV Cohort Study. Clin Infect Dis 2014; 59:1787-1797.
20. van Sighem AI, van de Wiel MA, Ghani AC, Jambroes M, Reiss P, Gyssens IC, et al., on behalf of the ATHENA Cohort Study Group. Mortality and progression to AIDS after starting highly active antiretroviral therapy. AIDS 2003; 17:2227-2236.
21. Onen NF, Agbebi A, Shacham E, Stamm KE, Onen AR, Overton ET. Frailty among HIV-infected persons in an urban outpatient care setting. J Infect 2009; 59:346-352.
22. Alberti KGMM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120:1640-1645.
23. Haringsma R, Engels GI, Beekman ATF, Spinhoven P. The criterion validity of the Center for Epidemiological Studies Depression Scale (CES-D) in a sample of self-referred elders with depressive symptomatology. Int J Geriatr Psychiatry 2004; 19:558-563.
24. Deeks SG, Tracy R, Douek DC. Systemic effects of inflammation on health during chronic HIV infection. Immunity 2013; 39:633-645.
25. Mezuk B, Edwards L, Lohman M, Choi M, Lapane K. Depression and frailty in later life: a synthetic review. Int J Geriatr Psychiatry 2012; 27:879-892.
26. Garcá-Esquinas E, José Garcá-Garcá F, León-Muñoz LM, Carnicero JA, Guallar-Castillón P, Gonzalez-Colaço Harmand M, et al. Obesity, fat distribution, and risk of frailty in two population-based cohorts of older adults in Spain. Obesity (Silver Spring) 2015; 23:847-855.
27. Crum-Cianflone N, Roediger MP, Eberly L, Headd M, Marconi V, Ganesan A, et al. Increasing rates of obesity among HIVinfected persons during the HIV epidemic. PLoS ONE 2010; 5:e10106.
28. McComsey GA, Moser C, Currier JS, Ribaudo H, Paczuski P, Dube MP, et al. Body composition changes after initiation of raltegravir or protease inhibitors [Abstract 140]. 2015 Conference on Retroviruses and Opportunistic Infections; 23-26 February 2015, Seattle, Washington, USA; 2015.
29. Desquilbet L, Jacobson LP, Fried LP, Phair JP, Jamieson BD, Holloway M, et al. A frailty-related phenotype before HAART initiation as an independent risk factor for AIDS or death after HAART among HIV-infected men. J Gerontol A Biol Sci Med Sci 2011; 66:1030-1038.
30. AkgünKM,TateJP,CrothersK,CrystalS,LeafDA,WomackJ,etal.An adapted frailty-related phenotype and the VACS index as predictors of hospitalization and mortality in HIV-infected and uninfectedindividuals. JAcquirImmuneDeficSyndr2014;67:397-404.
31. Guaraldi G, Brothers TD, Zona S, Stentarelli C, Carli F, Malagoli A, et al. A frailty index predicts survival and incident multimorbidity independent of markers of HIV disease severity. AIDS 2015; 29:1633-1641.